Trial Profile
Barrow ALA Trial for Recurrent Gliomas
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 07 Jan 2019
Price :
$35
*
At a glance
- Drugs Aminolevulinic acid (Primary)
- Indications Glioma
- Focus Pharmacodynamics
- 04 Jan 2017 Planned End Date changed from 1 Mar 2017 to 1 Sep 2017.
- 04 Jan 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Jun 2017.
- 25 Aug 2016 Planned End Date changed from 1 Sep 2016 to 1 Mar 2017.